Observation of Clinical Treatment Efficacy in Severe  Heart Failure of Geriatric Cardiology

Qi  Yuan

doi:https://doi.org/10.37155/2717-5278-0601-12

Home > Current

Observation of Clinical Treatment Efficacy in Severe Heart Failure of Geriatric Cardiology

Qi Yuan

https://doi.org/10.37155/2717-5278-0601-12

Abstract

Objective: To explore the clinical treatment efficacy of severe heart failure in geriatric cardiology.Methods: A total of 122 cases of severe heart failure patients admitted to our hospital from January 2022 to December 2023 were selected as the research subjects. The patients were divided into two groups using digital random grouping method, with 61 cases in each group. The control group was treated with metoprolol, while the experimental group was treated with metoprolol combined with eplerenone hydrochlorothiazide. The occurrence rate of adverse reactions and treatment efficacy of clinical indicators were compared between the two groups.Results: There was no significant difference in the incidence of adverse reactions (P > 0.05); the clinical indicators of the experimental group were better than those of the control group, and the total effective rate of treatment was higher than that of the control group. The difference in comparison results was statistically significant (P < 0.05). Conclusion: For the treatment of severe heart failure in geriatric patients in cardiology,metoprolol combined with eplerenone hydrochlorothiazide can be used, which can significantly improve the clinical signs of patients, increase the total effective rate of treatment, and will not significantly increase the risk of adverse reactions. It is worth further promotion and application.

Keywords

Cardiology; Severe heart failure; Geriatric patients

Full Text

PDF

References

[1] Zhou, S., Zhang, L., & Pan, Y. (2023). Analysis of the therapeutic effect of CRRT in acute left heart failure combined with renal insufficiency. Modern Diagnosis and Treatment, 34(14), 2185-2187.
[2] Lu, J. (2023). Clinical analysis of intravenous amiodarone infusion in the treatment of acute
heart failure combined with paroxysmal atrial fibrillation. Chinese Journal of Modern Drug
Application, 17(14), 96-99.
[3] Wang, H., & Shi, X. (2023). Observation on the effect of preventing complications in elderly patients with severe acute left heart failure treated with mechanical ventilation. Heilongjiang Medicine, 46(03), 122-124.
[4] Ding, C., Chu, Y., & Feng, J. (2022). Effect of recombinant human brain natriuretic peptide on elderly patients with acute left heart failure and its influence on myocardial injury markers. Practical Geriatrics, 36(10), 1042-1045.
[5] Fu, L. (2021). Clinical analysis of recombinant human brain natriuretic peptide in the treatment of acute exacerbation period of chronic heart failure in elderly patients. Contemporary Medicine, 27(05), 130-132.
[6] Xu, R., & Ye, Q. (2022). Analysis of the effect of rhBNP on elderly patients with acute
decompensated heart failure. Journal of Shandong Medical College, 42(06), 442-444.
[7] Liu, X. (2022). Effect of non-invasive mechanical ventilation on elderly patients with acute left heart failure and respiratory failure and its impact on their quality of life. Journal of Mathematical Medicine, 33(01), 56-57.
[8] Cao, Q. (2022). Clinical discussion on the treatment effect of elderly patients with acute left heart failure combined with diabetes and hypoglycemia. New World of Diabetes, (19), 94-96.

Publishing time:2024-02-27
This work is licensed under a Creative Commons Attribution 4.0 International License